Ideas to Innovation

In this concluding episode of Season 3 of "Ideas to Innovation," we reflect on our journey through the episodes published in 2024 that highlight the conversations we've enjoyed with some of the brightest minds in education, healthcare and intellectual property law.     In episode 6 in February, we explored America's literacy challenge with documentary filmmaker Jenny Mackenzie. Jenny shared her personal connection to literacy and discussed the innovative strategies being used to promote reading rights across the United States. Her insights into reading proficiency and educational reform were both eye-opening and inspiring.     March brought us a conversation with Renée Aguiar-Lucander, CEO of Calliditas Therapeutics, in episode 7, who detailed the groundbreaking journey of Tarpeyo, a drug that promises to revolutionize the treatment of kidney disease. Renée explained the innovative path to FDA approval, setting new benchmarks in the pharmaceutical industry.     We delved into the impact of artificial intelligence on intellectual property law in episode 8 in April, with Jay Myers from Seyfarth Shaw and Arun Hill from Clarivate. They provided valuable insights into how AI is transforming trademark searches, infringement monitoring and strategic brand decisions while addressing the ethical challenges that come with these advancements.     As we wrap up Season 3, we hope the episodes have informed, inspired, and entertained you. You can also listen to the Season 3 episodes from 2023 – our end-of-year episode summarizes the five stories we shared between September and December.      "Ideas to Innovation" will return later this year with more stories that showcase the power of human intellect and innovation.     Stay curious, and thank you for listening.  

In this episode of Ideas to Innovation, we delve into the transformative influence of artificial intelligence (AI) on intellectual property (IP) and trademark law. Our conversation with guests Jay Myers, Director of Innovation for the Intellectual Property Practice Group at the Seyfarth Shaw international law firm, and Arun Hill, Senior Consultant, The Clarivate Center for IP and Innovation Research, unravels the complexities of integrating AI into legal practices.   Our discussion illuminates AI's capacity to streamline trademark searches, enhance infringement monitoring, and inform strategic brand decisions. Yet, it also confronts the ethical dilemmas and practical challenges that accompany AI's rise in the legal domain.    As we peer into the near future, our guests speculate on an era marked by increased efficiency and higher-quality decision-making in IP law, driven by AI's augmentation of human expertise. This vision underscores the importance of balancing technological advancements with the indispensable elements of human judgment and ethical considerations.   This episode offers invaluable insights into how organizations can leverage AI to navigate the complexities of IP law, striking a balance between innovation and the critical human element of legal expertise.   Join us to explore how AI is not only automating tasks but also augmenting the capabilities of IP professionals to achieve higher-quality outcomes for their clients.  

The remarkable journey of Calliditas Therapeutics and its groundbreaking drug, Tarpeyo, sheds light on the company's innovative strategies and relentless pursuit of excellence that led to the successful approval of Tarpeyo by the U.S. Food and Drug Administration (FDA) for the treatment of a specific kidney disease. Our guest in this episode, Renée Aguiar-Lucander, CEO of Calliditas Therapeutics, reveals how their pioneering approach to drug development has set a new benchmark in the pharmaceutical industry.  We explore how Calliditas Therapeutics' groundbreaking work in securing FDA approval not only marks a significant milestone for the company but also inspires a new wave of innovation in the treatment of kidney diseases. Discover the power of pioneering drug development and the bright future it heralds for patients worldwide.  This episode also features insights from Mike Ward, Global Head of Life Sciences and Healthcare Thought Leadership at Clarivate, highlighting the importance of the Drugs to Watch 2024 report and the potential of Tarpeyo – one of 13 drugs to watch included in the report – to significantly improve patient outcomes.  Discover a story of resilience, innovation, and success behind Tarpeyo's journey to the American market, and the broader implications for the pharmaceutical industry's approach to drug development and regulatory approval. 

Season 03 Episode 06: Reading Rights: America's Literacy Challenge with Jenny Mackenzie

Over the past year, the Ideas to Innovation podcast from Clarivate took listeners on a special journey through a world where curiosity meets ingenuity. In each of 15 episodes published in 2023, we told stories of people thinking forward in the real world, highlighting those who not only dared to dream but also transformed their dreams into reality. Our conversations with experts weren't just talks; they were narratives of change, powerful examples of how fresh insights are solving some of the world's most complex challenges.   For this “Best of 2023” episode, we showcase three compelling stories, each of which serves a testament to the spirit of innovation. You'll first hear from an associate professor who is known as a ‘scientific sleuth' for his uncanny ability to identify falsified data in published academic research. Next, two guests share their stories about a rare hereditary disease, its devastating impacts and the role and work of scientific research in finding answers. In our final segment, an accomplished scientist, engineer, and innovator with 77 patents to her name talks about her work in breaking down complex problems, her most surprising discovery, and finding solutions that stick. We hope you enjoy this recap and continue joining us as we traverse a landscape rich in creativity and innovation, meeting extraordinary minds and witnessing their groundbreaking work in real time. 

Rapid advancements in technology and science are shaping a new era, with artificial intelligence and synthetic biology, or “syn-bio,” at the forefront. Heralded as the next big leap in science, syn-bio involves redesigning organisms for useful purposes by engineering them to have new abilities. The importance of syn-bio for people and our planet cannot be overstated. It offers novel ways of producing almost anything that human beings consume, from flavors and fabrics to foods and fuels. Today, the combination of syn-bio and AI – two of the most potent realms of science and technology – promises to unravel solutions to our most pressing challenges, including Earth's food and water, the environment and sustainability, bioenergy, and human health care.  One widely recognized trailblazer in syn-bio is Jim Collins, professor of medical engineering and science and professor of biological engineering at MIT. He is also a core founding faculty member of the Wyss Institute for Biologically Inspired Engineering at Harvard University. In the latest episode of the “Ideas to Innovation Season 3” podcast from Clarivate, Collins helps listeners navigate through the exciting but complex landscape of syn-bio. He also discusses what it was like to be named a Citation Laureate 2023 for his pioneering work in synthetic gene circuits, which launched the field of syn-bio. Each year since 2002, the Citation Laureates program from Clarivate recognizes a small group of highly cited scientists and economists whose influence is comparable to that of past and future Nobel Prize winners. 

Over the past half century, the semiconductor technology landscape has been evolving rapidly, underpinning the digital transformations we witness across the various spheres of life today. Sometimes referred to as integrated circuits or microchips, semiconductors are the backbone of modern electronics. In devices of every type, from simple gadgets to complex systems like computers, cars and household appliances, semiconductors have led to them being smaller or faster or more reliable. More inconspicuously, semiconductors are now enabling innovations in healthcare to flourish.    One company, imec, stands as a vanguard in this area. Their work promises to enable smart health concepts such as precision medicine and genomics to be brought within everyone's reach, resulting in personalized treatments with better outcomes and lower costs. Joining the latest episode of the “Ideas to Innovation Season 3” podcast from Clarivate is Peter Peumans, Chief Technology Officer - Healthcare Technologies and Senior Fellow at Belgium-based imec.  He and Ed White of Clarivate discuss how innovations in semiconductors led imec to be named one of 36 companies in this year's Innovators to Watch report from Clarivate. The report – guided by Ed in his role as vice president and principal analyst for IP and Innovation Research at Clarivate –identifies organizations that demonstrate both exceptional potential and above-the-bar innovation excellence. 

The concept of academic libraries has evolved from humble beginnings five thousand years ago to the expansive network that exists today in public schools, colleges, and universities across the United States. It's easy to see why libraries are worth supporting. They continue to facilitate academic excellence, embrace advancements in technology and foster community and collaboration. Still, looking ahead, academic libraries face several significant challenges, including – perhaps most importantly – the significant cost for their support.     Championing the cause of libraries is the mission of our latest guest on the “Ideas to Innovation Season 3” podcast from Clarivate. John Chrastka serves as executive director of EveryLibrary, a non-profit group that builds voter support for academic libraries and helps them secure funding as well. To advance this mission, Clarivate recently announced a partnership with EveryLibrary that leverages the strengths of the two organizations through dedicated resources and advocacy. John is long-time library trustee, supporter and advocate for academic libraries. Prior to his current role, he served as former partner in AssociaDirect, a Chicago, Illinois-based consultancy focused on support associations in membership recruitment, conference, and governance activities. 

Artificial intelligence is all around us and it's revolutionizing our world in many ways. In life sciences and healthcare, AI-powered technologies are instrumental in tasks such as diagnostics, precision medicine and even robotic surgery. And the transformative aspect of generative AI is already being felt in areas such as pharmaceutical research, epidemiology and telemedicine. There are projections that the global market for AI in life sciences and healthcare will be $6.7 billion USD by 2030. What is driving such remarkable growth and how rosy is this picture?     Joining us at the start of a new season three of the “Ideas to Innovation” podcast from Clarivate is Henry Levy, who has plenty to say about AI and what it will and won't enable us to achieve. Henry joined Clarivate earlier this year as President, Life Sciences and Healthcare (LS&H). He leads the teams focused on developing solutions that enable life sciences and healthcare companies and providers to create a healthier tomorrow by connecting them to transformative intelligence and data technology to improve patient lives. With more than 25 years of experience, Henry is the author of multiple articles on drug development and tech trends and a frequent speaker at industry forums. He holds a bachelor's degree in bioengineering from the University of Pennsylvania.

Today, innovation is key to driving business growth and competitive advantage, with intellectual property or IP sitting at the very heart of this strategy. In recent years we've witnessed some remarkable strides across the globe in bridging the gender gap in the IP sector. Yet, according to the World Intellectual Property Organization, only 16 percent of international patent applications are filed by women inventors. At this rate, the WIPO doesn't expect to achieve gender parity before 2064. That's almost 40 years into the future. So, while progress is being made, clearly much more must be done to quickly close this gap as well as a similar gap in career opportunities for minorities.    Tarianna Stewart – our featured guest in the latest episode of the Ideas to Innovation Season 2 podcast from Clarivate – ventured into her IP career by accident. “I happened to learn about IP during my Ph.D. program and thought, ‘this seems interesting… maybe a little bit better than working in the lab.'” Now an experienced biomedical scientist and accomplished IP professional at the technology unit of New York University in New York City, Tarianna has smart advice for women and people of color who seek to follow in her footsteps and pursue careers in IP and innovation. In our podcast discussion, she recalls how she “fell in love with the tech transfer space,” and offers a ‘been-there-done-that' perspective on what she believes it will take to foster a more inclusive IP and innovation landscape for the benefit of all involved. 

Maintaining belief in the truthfulness of what we see, read and hear has never been as difficult as it is today. While technology plays a huge role in this current state of affairs, most appalling is the human faker, someone who sets out to deceive and profit with sophisticated methods that pre-date the latest tech advances such as artificial intelligence or AI. In today's scientific research, fakery can be highly sophisticated, manifesting itself in areas like data and image falsification. Spotting dishonesty across virtual floods of information isn't easy. Challenging even the most egregious of lies can be tricky as well.     In our latest episode of “Ideas to Innovation Season 2,” we welcome an assistant professor who has been able to spot fakes in scientific research publications with uncanny accuracy, to such an extent, in fact, that this talent has earned him the moniker of the “scientific sleuth.” David A. Sanders, a virologist at Purdue University in West Lafayette, Indiana, argues that fraud is a serious academic issue that must be confronted head on, especially during this age of AI. Through the course of his work, David has become focused on the veracity of scientific literature and has called out publicly, including from the front page of The New York Times, the many times when there are violations of such truthful principles. He shares that it's important not only for him but for all scientists to point out violations of scientific norms and to discriminate between what is truthful and what is false.

A person born this year is expected to live about 73 years, according to the World Health Organization. But 73 doesn't reveal the full picture. According to a WHO report published in May, advances in science, related technologies and other factors have helped increase life expectancy worldwide by six years between 2000 and 2019.  Good news, right? However, it's also true that 80 percent of premature deaths could be avoided if patients and healthcare professionals had the right information at the right time to make better decisions. That's where artificial intelligence comes in. Today, Patient Connect, a biopharma intelligence company that's part of Clarivate, is integrating AI into clinical software at point of care for patients around the world, such as, for example, the two million people in the U.S. who suffer from heart failure. These new AI tools are enabling more than a million physicians to provide better care for those suffering from a wide variety of diseases by identifying the most at-risk patients or the patients with the most unmet needs.     To explain how such sophisticated solutions provide better and best care for patients, we welcome back Dr. Grace Lomax to the “Ideas to Innovation Season 2” podcast from Clarivate. Grace founded Patient Connect with her sister, Zoe Barker, in 2008, and the company was acquired by Clarivate in 2021. Patient Connect engagement solutions improve patient outcomes by delivering clinical messaging to the workflows of physicians and pharmacists at the point of patient contact. This messaging helps guide patients to better understand their treatment and disease and empower them to make informed healthcare decisions.     For more information on the many ways Clarivate is using AI to deliver the highest quality content and insights to customers, go to www.clarivate/ai 

Among the consequences of COVID-19 is its adverse impact on the mental health and wellbeing among university students in the United States.  Today's students deal with many challenges from coursework, relationships and adjustments to campus life, to economic strain, social injustice, mass violence and various forms of loss related to the pandemic. In a 2021 survey, nearly 75 percent of college presidents listed students' mental health as their most pressing issue. And key findings from a report released this year by non-profit Mental Health America shows more than 10 percent of young people are experiencing depression that severely impairs their ability to function at school or work, at home, with family or in their social life.  Many school leaders have started to think outside the box about how to help. They're finding ways to incorporate a broader culture of wellness into their policies, systems and day-to-day campus life. In this episode of “Ideas to Innovation Season 2” from Clarivate, we speak with Lisa O'Donnell, assistant professor for the department of social work at Wayne State University in Detroit, Michigan. An expert in bipolar disorder and severe mental illness, she brings a compelling perspective to the topic of university students and mental health. Lisa has served as a clinician for the state of Michigan for more than 18 years, primarily working with adults who have severe mental illness as well as anxiety disorders and OCD-related disorders.   For information on subscriptions to mental health e-books from ProQuest, part of Clarivate, go to https://bit.ly/proquestmentalhealth 

Season 2 Episode 17: Artificial Intelligence: Building bridges between science and policy with Jaron Porciello

Season 2 Episode 16: Seismic shifts in the global research landscape with Jonathan Adams and David Pendlebury

Approximately 35,000 people worldwide have LHON, a genetic condition that affects the optic nerve, which sends visual information from the eye to the brain. In most cases, LHON – short for Leber's hereditary optic neuropathy – leads to severe vision loss in both eyes, usually beyond the threshold of legal blindness and mostly among young men. In this episode of Ideas to Innovation Season 2, two special guests discuss the challenges of this rare disease on patients and their families. They help explain, too, the role and work of scientific research in seeking answers.  Read more - https://clarivate.com/podcasts/ideas-to-innovation-season-two/  

Every year, Clarivate publishes a list of the Top 100 Global Innovators, companies and organizations that sit at the very top of the global innovation ecosystem, with the most consistent over-the-bar performance in innovation. Since the list began in 2012, only 19 companies can claim the distinction of being recognized continuously, year after year. One such company is 3M – the iconic global manufacturer and distributor well known for its cutting-edge scientific research and invention of groundbreaking products such as Post-it ® Notes, Scotchgard ™ Fabric Protector, and Thinsulate™ Insulation. In our latest episode of Ideas to Innovation Season 2, we'll learn how 3M is constantly pushing the boundaries of what's possible with science and innovation, where the power of science and the spark of human ingenuity come together in perfect harmony.    Read more - https://clarivate.com/podcasts/ideas-to-innovation-season-two/  

From journalist Ida B. Wells to poet Maya Angelou to Aretha Franklin, the queen of soul music, Black women have made important contributions to the United States in a variety of areas, including politics, science, the arts, and social justice. Celebrating and recognizing Black women during Women's History Month is an important way to honor their legacy and inspire future generations.  In this episode we talk about how Black women have played a crucial role in advancing human rights and freedoms, contributing to our knowledge base, and improving our world with Dr. Ashley Farmer an associate professor in the Departments of History and African and African Diaspora Studies at the University of Texas at Austin.  Read more - https://clarivate.com/podcasts/ideas-to-innovation-season-two/  

In February 2023, we celebrated women in science around the world for their significant contributions to science, technology, engineering and mathematics, collectively known as STEM.   In this episode we discuss the achievements and challenges for women in science and for girls who are thinking about careers in STEM fields with Dr. Rachel Webster, Director, Healthcare Research and Data Analysis, Oncology and Biosimilars at Clarivate.  Read more - https://clarivate.com/podcasts/ideas-to-innovation-season-two/  

Securing A Livable Earth – Experts' Latest Look at Renewable Energy  

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

Through its Citation Laureates program, Clarivate recognises individuals whose research publications are highly cited and whose contributions to their fields have been extremely influential, even transformative. This year, we named twenty world-class researchers from four countries as Citation Laureates. These are researchers whose work is deemed to be ‘of Nobel class', as demonstrated by analysis carried out by the ISI, and who are in the running for future Nobel honours. In this episode, you'll hear from two of this year's Citation Laureates who share insights into their work, how they got started, tips for young researchers, and more - Mary-Claire King, Professor of Medicine and of Genome Sciences, School of Medicine, at the University of Washington in Seattle, in the United States, recognized for demonstrating inherited susceptibility for breast and ovarian cancer and discovering the role played by mutations of the BRCA1 gene and Zhenan Bao, the K.K. Lee Professor of Chemical Engineering, and Director, Stanford Wearable Electronics Initiative (eWEAR), at Stanford University, California, recognized for the development of novel biomimetic applications of organic and polymeric electronic materials, including flexible ‘electronic skin.' Hosted on Acast. See acast.com/privacy for more information.

Today, with so much information available online, verification of information – who created it and who shared it – has become part of standard operating procedures in many enterprises to create a climate of trust surrounding information that can be used and acted upon. Nowhere is this truer than in the field of scientific research and reporting. In this episode, Nandita Quaderi, editor-in-chief for the Web of Science™ at Clarivate, shares her views on the topic of research integrity. She describes the importance of conducting and presenting research in a way that allows others to have trust and confidence in the methods used. And she warns of the dangers that occur in instances when the scholarly record cannot be trusted. Hosted on Acast. See acast.com/privacy for more information.

The healthcare industry worldwide is changing. Hospitals and healthcare systems in many countries are struggling to control costs, increase revenues, train and retain skilled employees, and treat and care for patients. In the business of health care, new approaches and ideas are coming to the fore as part of this journey to transform healthcare and ultimately change patients' lives. In this episode, podcast host Neville Hobson joins guests Mike Ward, Global Head of Life Sciences and Healthcare Thought Leadership at Clarivate, and Jerry Harrison, Rock and Roll Hall of Fame inductee as a member of Talking Heads, and healthcare and life sciences business entrepreneur, to discuss new approaches to investment that connect financial and human capital to communities in the healthcare space that share knowledge, interest and passion for healthcare innovation. And we examine how innovation is bringing some startling ideas in healthcare to life. Our GDPR privacy policy was updated on August 8, 2022. Visit acast.com/privacy for more information.

While some say such manmade natural disasters are the new normal that we'll experience more strongly and more frequently in the future, others point the way to manmade solutions that help us take care of our environment through innovative efforts like reducing traffic pollution, and the emissions that contribute to climate extremes. In this podcast, our guest Ingrid Gogl, the vice president of marketing and communications at Yunex Traffic will put such manmade disasters in context as we consider how one company in Germany is initiating a mobility revolution that aims to protect our climate as much as it does to improve traffic safety. See acast.com/privacy for privacy and opt-out information.

Every year, nearly 41 million people worldwide die prematurely from non-communicable diseases. Yet 80% of premature deaths could be avoided if patients and healthcare professionals alike had the right information at the right time to make better decisions.In this podcast Dr. Grace Lomax, the Clinical Director at Patient Connect, a part of Clarivate, shares her experience as a physician highlighting numerous unmet needs beyond just clinical issues – especially around healthcare literacy and education at the point of care. See acast.com/privacy for privacy and opt-out information.

For more than a decade, Ukraine has been a valuable part of scientific research with over 52,000 papers, many highly cited, written by Ukrainian researchers. This essential work came to a halt when Russia invaded Ukraine in February 2022. In this podcast Gali Halevi, Director at the Institute for Scientific Information at Clarivate, shares her perspectives on the impact on scientific research and discovery and how Clarivate is supporting displaced researchers in Ukraine. See acast.com/privacy for privacy and opt-out information.

Have you ever thought about how innovation comes into the world? In Ideas to Innovation Season 2, we'll continue talking to some remarkable people who have been on journeys to find creative solutions to the toughest of business challenges. Watch out for the first episode on your favorite podcast app. See acast.com/privacy for privacy and opt-out information.

In today's episode, we look at the state of the global innovation landscape and the direction of ideas still to come, as revealed by Top 100 Global Innovators 2022 from Clarivate – an annual list that recognizes the organizations that demonstrate consistent, above-the-bar innovation excellence and which sit at the very top of the global innovation ecosystem. Joining us are Davy Brown, Vice President and Chief Technology Officer of Industrial Solutions for TE Connectivity and Ed White, Chief Analyst and Vice President of IP and Innovation Research, at Clarivate. See acast.com/privacy for privacy and opt-out information.

Luxury brands have a timeless appeal and consumers associate them with superior quality and exclusivity. In turn, these brands command premium prices for their products. Luxury brands are masters when it comes to the art of brand building, and they have consistently excelled at evoking quality and prestige.Joining us today to discuss how luxury brand owners are adapting to today's volatile and increasingly digital environment are several subject matter experts from Clarivate: Arun Hill, Analytics Consultant; Prudence Malinki, Senior Manager, Global Industry Relations; and David Marques, Principal Consultant, Litigation Products & Strategy. See acast.com/privacy for privacy and opt-out information.

Clarivate recently unveiled its annual list of Highly Cited Researchers, the “who's who” of the world's influential scientists and social scientists. The list from the Institute for Scientific Information recognizes some 6,600 researchers for demonstrating significant influence among their peers, as evidenced by the production of multiple highly cited papers that rank in the top 1% by citations for field and year, as indexed in the Web of Science over the last decade. Joining us today are David Pendlebury, Head of Research Analysis at the Institute for Scientific Information; Professor Liu Bin, Vice President of Research and Technology at the National University of Singapore; and Dr. Robin Drennan, Director of Research and Innovation at the University of the Witwatersrand, Johannesburg in South Africa. See acast.com/privacy for privacy and opt-out information.

Two years into a global pandemic, innovation, at speed, continues unabated. Collaboration across borders remains strong, thanks to technological advancements in connectivity and mobile communications. Social interaction is evolving, as the physical and virtual world collide with the rise of the metaverse. Expertise at a distance, including remote medicine, is becoming more pervasive. Sustainability sits at the core of the agenda for businesses, government and society.As the world continues its tentative recovery, what does 2022 and beyond hold for us? Joining us today are Zaid Al-Nassir, Principal Analyst for Medical Technology, Lin Wang, Portfolio Marketing Manager, and Arun Hill, Principal Consultant, all from Clarivate. See acast.com/privacy for privacy and opt-out information.

Clarivate recently unveiled its annual list of Highly Cited Researchers, the “who's who” of the world's influential scientists and social scientists. The list from the Institute for Scientific Information recognizes some 6,600 researchers for demonstrating significant influence among their peers, as evidenced by the production of multiple highly cited papers that rank in the top 1% by citations for field and year, as indexed in the Web of Science over the last decade. An outstanding faculty is the lifeblood of every notable research institution, and this year Highly Cited Researchers are based at more than 1,300 institutions all over the world. In this episode we speak to representatives from some of these universities, hospitals, research institutions, laboratories and government organizations about how they excel in a competitive global environment – supporting their Highly Cited Researchers in a way that encourages collaboration, facilitates career growth and accelerates highly innovative research. See acast.com/privacy for privacy and opt-out information.

It has been a decade since the Clarivate Top 100 Global Innovators was conceived. Every year, for the last decade, Clarivate has honored the companies and institutions across the world that represent innovation at its finest.Today, we welcome guests from two of this year's Top 100 Global Innovators to talk about creating and sustaining an innovative company through fast changing and challenging times. We also talk about the sustainability agenda, how it must work hand in hand with, not just the cycle of innovation, but indeed, be an integral part of companies' fabric if we are to secure a livable and resilient world, today and for generations to come. See acast.com/privacy for privacy and opt-out information.

Actors have their Oscars, and researchers have their Nobels. The Nobel prize has been the global pinnacle symbol of achievement in science since 1901 and economics since 1969. Each year since 2002, the Institute for Scientific Information (ISI)™ at Clarivate has identified a small group of Citation Laureates™: exceptionally highly cited scientists and economists whose influence is comparable to past and future Nobel prize winners. So far, 64 Citation Laureates have gone on to win a Nobel Prize, including five this year in 2021. Joining us are David Pendlebury, Head of Research Analysis at the Institute for Scientific Information, and David Audretsch, Distinguished Professor and Ameritech Chair of Economic Development with the O'Neill School of Public and Environmental Affairs at Indiana University, who has recently been named a Citation Laureate for 2021. Together we explore what it takes to win a Nobel Prize, and how Clarivate uses both quantitative and qualitative analysis to predict Nobel success, often years before a Nobel Prize is given. We discuss the fundamental role that citations play in identifying these giants of research, and how it feels to join the ranks of other ‘Nobel-class' researchers in the Hall of Citation Laureates. See acast.com/privacy for privacy and opt-out information.

COVID-19 is an enormous global challenge that has required an unprecedented level of engagement by stakeholders within pharma, research and policy. While SARS-CoV-2 emerged as a novel virus to which humans had no immunity, infection control measures have been deployed and existing as well as new and emerging technologies are being leveraged to speed the development of new treatments and therapies. Clarivate partnered with pharma in an international effort to bring life-saving vaccines to market.Joining us in this new episode of Ideas to Innovation are Clarivate experts Danielle Waterman, Senior Quality Specialist, Lynn Yoffee, Publisher BioWorld, and Kevin Yin, Senior Analyst – Medtech Insights, to provide a snapshot of key milestones over the past year and share their perspectives on what is to come. They discuss key medical responses to the pandemic, what the “new normal” looks like and offer analysis and a review of the latest data and insights that can provide a complete view of the healthcare landscape. See acast.com/privacy for privacy and opt-out information.

Over the past decade, Clarivate has identified the Top 100 Global Innovators, the companies and institutions at the pinnacle of the global innovation landscape that have contributed new ideas, solved some of the world's most complex challenges and created new value.Today, we have a guest speaker from Thales, one of those 100 companies join us to talk about how businesses today go about creating and sustaining an innovative company, the complexity of modern-day innovation and how it continues to fascinate and inspire. Our guest speaker is Bernhard Quendt, Chief Technical Officer and Senior Vice President at Thales joining Ed White, Head of Analytics, IP Group at Clarivate. See acast.com/privacy for privacy and opt-out information.

In a new report from Clarivate, The road ahead: sustainable vehicles today and in the future, we look at the fascinating history of the electric vehicles, the innovation spark that finally fueled its mass market production and wider consumer acceptance, and the state of innovation in the electric vehicles sector today.Today, we have subject matter experts from Clarivate talking about the new report and the electric vehicles which count among the handful of modern-day inventions that have truly captured our imagination.Our speakers today are Ed White, Head of Analytics, Robert Reading, Director of Government and Content Strategy, Brian King, Head of Policy and Advocacy and David Marques, Principal Consultant, Litigation Products & Strategy. See acast.com/privacy for privacy and opt-out information.

In a new report from Clarivate, The road ahead: sustainable vehicles today and in the future, we look at the fascinating history of the electric vehicles, the innovation spark that finally fueled its mass market production and wider consumer acceptance, and the state of innovation in the electric vehicles sector today.Today, we have subject matter experts from Clarivate talking about the new report and the electric vehicles which count among the handful of modern-day inventions that have truly captured our imagination. Our speakers today are Ed White, Head of Analytics, Robert Reading, Director of Government and Content Strategy, Brian King, Head of Policy and Advocacy and David Marques, Principal Consultant, Litigation Products & Strategy. See acast.com/privacy for privacy and opt-out information.

Every year since 2012, Clarivate identifies the Top 100 Global Innovators. These are companies and institutions at the pinnacle of the global innovation landscape that have contributed new ideas, solved some of the world's most complex challenges and created new value.Today, we have a guest from Boston Scientific, one of those 100 companies and institutions join us to talk about the value of innovation culture, how businesses today go about creating and sustaining an innovative company and embracing the sustainability imperative.Our guest speaker is David Knapp, Vice President of Research and Development for Peripheral Interventions at Boston Scientific joining Ed White, Head of IP Analytics at Clarivate. See acast.com/privacy for privacy and opt-out information.

For almost 50 years, the global research community has relied on the data in the Journal Citation Reports (JCR)™ to identify the world's leading journals. The JCR is based on data from the Web of Science™, the world's largest publisher-neutral global citation database, and its journal intelligence metrics play a key role for funders, institutions, librarians and researchers. Academic publishers across the globe use the reports to evaluate their journals' impact in their field and promote them to the research community – so each year's update is met with great anticipation. In this episode we welcome guests from the Institute for Scientific Information™ at Clarivate, as well as publishers Hindawi, Frontiers and SAGE Publishing, to talk about the recent 2021 Journal Citation Reports release and the treasure trove of new features inside. Together we'll be exploring the fundamental role the JCR plays in supporting academic research and accelerating the pace of innovation by providing transparent, publisher-neutral journal intelligence and helping those in the research community make better informed, more confident decisions. See acast.com/privacy for privacy and opt-out information.

On June 7th, the U.S. Food and Drug Administration approved aducanumab, the first new Alzheimer's treatment since 2003. Aducanumab is a monoclonal antibody that has been shown to reduce the build up of a protein known as beta amyloid that some think might be one of the possible causes of Alzheimer's disease. While the approval has been applauded by some, it is not without controversy. We will be asking our guests how innovation in the search for treatments of Alzheimer's disease is evolving.Our guest speakers are Mei Mei Hu, Chief Executive Officer at Vaxxinity, Hans J. Moebius, Chief Medical Officer at Athira Pharma, Raymond J Tesi, Chief Executive Officer and Chief Medical Officer at Inmune Bio, as well as Jerre Stead, Executive Chairman and Chief Executive Officer of Clarivate Plc, and Jonathan Searles, Senior Director on the CNS/Ophthalmology therapy team at Clarivate. See acast.com/privacy for privacy and opt-out information.

Welcome to the ‘Ideas to Innovation' podcast. In this brand-new series, we'll engage in conversation with experts and industry leaders to discuss innovation at its core. In this episode we have guests from three of the Top 100 Global Innovator companies and institutions join us to talk about the value of innovation culture and how businesses today go about creating and sustaining an innovative company. We will be asking our guests how innovation is helping the world overcome the pandemic and deliver green shoots of recovery.Our guest speakers are Catherine Maresh, Vice President and Chief Intellectual Property Counsel at Immersion, Elizabeth McCombs, Senior Vice President for Medical Segment Research and Development at BD, Erin Byrne, Vice President and Chief Technology Officer for Data and Devices at TE Connectivity and Ed White, Head of Analytics for the IP Group at Clarivate. See acast.com/privacy for privacy and opt-out information.

Introducing the 'Ideas to Innovation' podcast from Clarivate. Learn more about Clarivate and what's coming up in the episodes that will follow. See acast.com/privacy for privacy and opt-out information.